|
Aug 7
|
Chips, Glorious Chips!
|
|
Aug 7
|
Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down
|
|
Aug 7
|
Zimmer Biomet (ZBH) Beats on Q2 Earnings, Cuts Revenue View
|
|
Aug 7
|
Globus Medical (GMED) Q2 Earnings Top Estimates, '24 View Up
|
|
Aug 7
|
STERIS (STE) Q1 Earnings Beat Estimates, Operating Margin Falls
|
|
Aug 7
|
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
|
|
Aug 7
|
Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
|
|
Aug 7
|
CVKD: Cadrenal Therapeutics and Abbott Collaborate on Novel Anticoagulant for LVAD Patients
|
|
Aug 7
|
3 Dividend Growth Stocks to Buy Hand Over Fist in August
|
|
Aug 6
|
Are Street Analysts Bullish on Abbott Laboratories (ABT) Right Now?
|
|
Aug 6
|
Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs
|
|
Aug 3
|
Abbott Laboratories Second Quarter 2024 Earnings: EPS Misses Expectations
|
|
Aug 3
|
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
|
|
Aug 2
|
Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered
|
|
Aug 2
|
Abbott (ABT) Just Overtook the 200-Day Moving Average
|
|
Aug 2
|
ResMed's (RMD) Q4 Earnings Surpass Estimates, Margins Expand
|
|
Aug 2
|
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
|
|
Aug 2
|
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
|
|
Aug 1
|
BD (BDX) Q3 Earnings Surpass Estimates, Margins Expand
|
|
Aug 1
|
Avanos (AVNS) Q2 Earnings Top Estimates, Gross Margin Contracts
|